| 1 |
Chang MC, Chen JH, Lee HN, Chen SY, Zhong BH, Dhingra K, Pan YH, Chang HH, Chen YJ, Jeng JH. Inducing cathepsin L expression/production, lysosomal activation, and autophagy of human dental pulp cells by dentin bonding agents, camphorquinone and BisGMA and the related mechanisms. Biomater Adv 2023;145:213253. [PMID: 36563508 DOI: 10.1016/j.bioadv.2022.213253] [Reference Citation Analysis]
|
| 2 |
Hu H, Zhu X, Zhang X, Huang G. Effects of combination treatment using arsenic trioxide and resveratrol on human breast cancer (MCF-7) cells.. [DOI: 10.21203/rs.3.rs-2007998/v1] [Reference Citation Analysis]
|
| 3 |
Fang Y, Zhang Z. Arsenic trioxide as a novel anti-glioma drug: a review. Cell Mol Biol Lett 2020;25:44. [PMID: 32983240 DOI: 10.1186/s11658-020-00236-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 4 |
Seo SU, Woo SM, Kim MW, Lee HS, Kim SH, Kang SC, Lee EW, Min KJ, Kwon TK. Cathepsin K inhibition-induced mitochondrial ROS enhances sensitivity of cancer cells to anti-cancer drugs through USP27x-mediated Bim protein stabilization. Redox Biol 2020;30:101422. [PMID: 31901727 DOI: 10.1016/j.redox.2019.101422] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 5 |
Ota A, Wahiduzzaman M, Hosokawa Y. Arsenic-Based Anticancer-Combined Therapy: Novel Mechanism Inducing Apoptosis of Cancer Cells. Current Understanding of Apoptosis - Programmed Cell Death 2018. [DOI: 10.5772/intechopen.74824] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 6 |
Sun Y, Wang C, Wang L, Dai Z, Yang K. Arsenic trioxide induces apoptosis and the formation of reactive oxygen species in rat glioma cells. Cell Mol Biol Lett 2018;23:13. [PMID: 29610575 DOI: 10.1186/s11658-018-0074-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 7 |
Sui H, Shi C, Yan Z, Wu M. Overexpression of Cathepsin L is associated with chemoresistance and invasion of epithelial ovarian cancer. Oncotarget 2016;7:45995-6001. [PMID: 27351223 DOI: 10.18632/oncotarget.10276] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 8 |
Minatel BC, Sage AP, Anderson C, Hubaux R, Marshall EA, Lam WL, Martinez VD. Environmental arsenic exposure: From genetic susceptibility to pathogenesis. Environ Int 2018;112:183-97. [PMID: 29275244 DOI: 10.1016/j.envint.2017.12.017] [Cited by in Crossref: 121] [Cited by in F6Publishing: 122] [Article Influence: 20.2] [Reference Citation Analysis]
|
| 9 |
Primon M, Huszthy PC, Motaln H, Talasila KM, Miletic H, Atai NA, Bjerkvig R, Lah Turnšek T. Cathepsin L silencing increases As2O3 toxicity in malignantly transformed pilocytic astrocytoma MPA58 cells by activating caspases 3/7. Exp Cell Res 2017;356:64-73. [PMID: 28412241 DOI: 10.1016/j.yexcr.2017.04.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 10 |
Podergajs N, Motaln H, Rajčević U, Verbovšek U, Koršič M, Obad N, Espedal H, Vittori M, Herold-Mende C, Miletic H, Bjerkvig R, Turnšek TL. Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells. Oncotarget 2016;7:593-609. [PMID: 26573230 DOI: 10.18632/oncotarget.5477] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 11 |
Motaln H, Koren A, Gruden K, Ramšak Ž, Schichor C, Lah TT. Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance. Oncotarget 2015;6:40998-1017. [PMID: 26517510 DOI: 10.18632/oncotarget.5701] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 12 |
Mujokoro B, Adabi M, Sadroddiny E, Adabi M, Khosravani M. Nano-structures mediated co-delivery of therapeutic agents for glioblastoma treatment: A review. Mater Sci Eng C Mater Biol Appl 2016;69:1092-102. [PMID: 27612807 DOI: 10.1016/j.msec.2016.07.080] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 13 |
Fei Y, Xiong Y, Zhao Y, Wang W, Han M, Wang L, Tan C, Liang Z. Cathepsin L knockdown enhances curcumin-mediated inhibition of growth, migration, and invasion of glioma cells. Brain Res 2016;1646:580-8. [PMID: 27373979 DOI: 10.1016/j.brainres.2016.06.046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 14 |
Zhang H, Zhang L, Wei L, Gao X, Tang LI, Gong W, Min NA, Zhang LI, Yuan Y. Knockdown of cathepsin L sensitizes ovarian cancer cells to chemotherapy. Oncol Lett 2016;11:4235-9. [PMID: 27313771 DOI: 10.3892/ol.2016.4494] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 15 |
Li L, Gao L, Song Y, Qin ZH, Liang Z. Activated cathepsin L is associated with the switch from autophagy to apoptotic death of SH-SY5Y cells exposed to 6-hydroxydopamine. Biochem Biophys Res Commun 2016;470:579-85. [PMID: 26797274 DOI: 10.1016/j.bbrc.2016.01.102] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 16 |
Perche F, Biswas S, Patel NR, Torchilin VP. Hypoxia-Responsive Copolymer for siRNA Delivery. Methods Mol Biol 2016;1372:139-62. [PMID: 26530922 DOI: 10.1007/978-1-4939-3148-4_12] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Wang W, Long L, Wang L, Tan C, Fei X, Chen L, Huang Q, Liang Z. Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro. Cancer Lett 2016;371:274-84. [PMID: 26706414 DOI: 10.1016/j.canlet.2015.12.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 18 |
Balça-Silva J, Matias D, do Carmo A, Girão H, Moura-Neto V, Sarmento-Ribeiro AB, Lopes MC. Tamoxifen in combination with temozolomide induce a synergistic inhibition of PKC-pan in GBM cell lines. Biochim Biophys Acta 2015;1850:722-32. [PMID: 25554223 DOI: 10.1016/j.bbagen.2014.12.022] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 19 |
Wang J, Li Y, Jiang C. MiR-133b contributes to arsenic-induced apoptosis in U251 glioma cells by targeting the hERG channel. J Mol Neurosci 2015;55:985-94. [PMID: 25355491 DOI: 10.1007/s12031-014-0455-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Zhong L, Wang Y, Li W, Gu J, Li X, Wang X, Yue Z, Mu Y, Bai J, Li R, Zhang H. Heme oxygenase-1 silencing increases the sensitivity of human osteosarcoma MG63 cells to arsenic trioxide. Mol Cell Biochem 2014;392:135-44. [PMID: 24676542 DOI: 10.1007/s11010-014-2027-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
